Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
China · Delayed Price · Currency is CNY 10.36
-0.25 (-2.36%)
Jun 3, 2026, 1:34 PM CST
Shanghai No.1 Pharmacy Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 76.27 | 57.75 | 163.06 | 89.28 | 143.56 | 49.42 |
Depreciation & Amortization | 68.82 | 68.82 | 65.72 | 54.01 | 48.32 | 45.19 |
Other Amortization | 8.6 | 8.6 | 6.37 | 5.77 | 4.82 | 5.51 |
Loss (Gain) From Sale of Assets | -50.18 | -50.18 | -169.18 | -65.13 | -0.05 | -1.48 |
Asset Writedown & Restructuring Costs | 1.64 | 1.64 | 5.28 | 5.09 | 20.07 | 0.14 |
Loss (Gain) From Sale of Investments | -11.06 | -11.06 | -13.28 | -23.86 | -4.41 | -1.94 |
Provision & Write-off of Bad Debts | 0.47 | 0.47 | -19.17 | 9.59 | 16.62 | 0.52 |
Other Operating Activities | -16.32 | 6.56 | 2.45 | 11.39 | 21.31 | 4.81 |
Change in Accounts Receivable | -27.82 | -27.82 | 50.13 | -3.72 | -124.06 | -43.24 |
Change in Inventory | -18.95 | -18.95 | -3.89 | 11.02 | -123.95 | -1.01 |
Change in Accounts Payable | 56.59 | 56.59 | -42.75 | -44.54 | 153.93 | -17.21 |
Operating Cash Flow | 84.53 | 88.88 | 49.03 | 58.49 | 132.31 | 36.56 |
Operating Cash Flow Growth | 64.61% | 81.29% | -16.18% | -55.79% | 261.91% | -56.60% |
Capital Expenditures | -14.05 | -15.93 | -51.94 | -13.88 | -11.37 | -12.64 |
Sale of Property, Plant & Equipment | 50.79 | 50.84 | 183.72 | 62.09 | 0.06 | 2.24 |
Investment in Securities | -38.63 | -89.33 | -65.88 | 95.19 | -121.01 | -51.01 |
Other Investing Activities | 18.31 | 18.64 | 9.46 | 23.74 | 4.54 | 2.16 |
Investing Cash Flow | 16.42 | -35.78 | 75.36 | 167.14 | -127.78 | -59.24 |
Short-Term Debt Issued | - | 99.29 | 144.05 | 95.07 | 870 | - |
Total Debt Issued | 99.29 | 99.29 | 144.05 | 95.07 | 870 | - |
Short-Term Debt Repaid | - | -144.28 | -144.47 | -320 | -550 | -180 |
Long-Term Debt Repaid | - | -62.39 | -67.34 | -57.95 | -43.44 | -33.62 |
Total Debt Repaid | -220.52 | -206.67 | -211.82 | -377.95 | -593.44 | -213.62 |
Net Debt Issued (Repaid) | -121.24 | -107.38 | -67.77 | -282.88 | 276.56 | -213.62 |
Common Dividends Paid | -50.94 | -50.79 | -29.41 | -48.18 | -27.41 | -22.44 |
Other Financing Activities | 3.33 | - | 1.47 | - | - | - |
Financing Cash Flow | -168.85 | -158.17 | -95.71 | -331.06 | 249.15 | -236.06 |
Foreign Exchange Rate Adjustments | -1.41 | -1.27 | 0.46 | 0.52 | 0.6 | -0.04 |
Net Cash Flow | -69.3 | -106.35 | 29.14 | -104.9 | 254.28 | -258.78 |
Free Cash Flow | 70.48 | 72.95 | -2.91 | 44.61 | 120.94 | 23.92 |
Free Cash Flow Growth | 279.77% | - | - | -63.11% | 405.61% | -66.78% |
Free Cash Flow Margin | 3.34% | 3.43% | -0.15% | 2.45% | 4.55% | 1.71% |
Free Cash Flow Per Share | 0.32 | 0.33 | -0.01 | 0.20 | 0.54 | 0.11 |
Cash Income Tax Paid | 46.21 | 51.07 | 104.14 | 84.74 | 122.11 | 51.08 |
Levered Free Cash Flow | 26.02 | 73.7 | 26.19 | 19.81 | 82.52 | -0.94 |
Unlevered Free Cash Flow | 28.49 | 76.52 | 29.97 | 24.56 | 91.34 | 1.03 |
Change in Working Capital | 6.28 | 6.28 | 7.77 | -27.64 | -117.94 | -65.61 |